ZNF268 and erythroleukemia: Here, we investigated the mechanism underlying decreased expression of ZNF268 as well as the consequences of ZNF268 downregulation in K562 cells, a human erythroleukemia cell line derived from a patient with chronic myelogenous leukemia [26], [27], [28].